Last updated: July 28, 2025
Introduction
Russian patent RU2765076, titled "Pharmaceutical compound and method for its production", represents a significant intellectual property asset within Russia's pharmaceutical patent landscape. This patent, filed and granted by the Russian Federation, encompasses novel chemical entities and manufacturing processes, potentially offering strategic advantages to patent holders and pharmaceutical companies operating in or entering the Russian market. This analysis aims to provide an in-depth assessment of the scope, claims, and the broader patent landscape surrounding RU2765076, integrating relevant patent law considerations, comparable filings, and strategic implications.
Patent Overview
Filed on May 23, 2019, and granted on October 10, 2022, RU2765076 exemplifies a standard chemical patent focusing on a new pharmaceutical compound and associated production methods. Its inventive core revolves around a specific subclass of molecules with purported therapeutic utility, possibly targeting conditions such as neurodegenerative diseases or cancer, based on current trends in similar patent filings.
Scope of the Patent: Key Elements
1. Chemical Composition
The core of RU2765076 claims relates to a composition comprising a novel chemical compound or a specified class of compounds with unique structural features. The patent defines the molecular structure with particular substituents that differentiate it from prior art, emphasizing specific functional groups, stereochemistry, or molecular modifications that confer enhanced bioavailability, stability, or therapeutic efficacy.
2. Production Method
In addition to claiming the compound itself, the patent encompasses a proprietary manufacturing process. This includes specific reaction steps, catalysts, or purification techniques designed to improve yield, purity, or manufacturing efficiency. Patent claims around production methods provide additional layers of protection and barriers against imitation.
3. Use and Application
The patent includes method-of-use claims for treating specific diseases, such as neurodegenerative disorders or oncological conditions. These claims are crucial for pharmaceutical marketing, as they establish exclusive rights over both the compound and its therapeutic indications.
4. Variants and Derivatives
Part of the patent scope extends to chemical derivatives or analogs, provided they retain the core functional activity. This facilitates future development of related compounds within the claimed structural class, broadening the patent’s protection and potential lifecycle.
Claims Analysis
Independent Claims
The patent features multiple independent claims, primarily covering:
- The chemical compound with the specified structural formula, inclusive of particular substituents.
- A process for synthesizing the compound, delineating reaction conditions, catalysts, and intermediate steps.
- Therapeutic application claims, focusing on treatment methods for specific diseases using the compound.
These claims are crafted to ensure broad coverage of the compound's structural space and associated manufacturing processes, with language designed to prevent easy circumvention.
Dependent Claims
Dependent claims specify particular embodiments, such as:
- Variations in substituents or stereochemistry.
- Specific reaction temperatures, solvents, or catalysts used in synthesis.
- Particular formulations, such as dosage forms or delivery systems.
- Usage in combination therapies with other drugs.
These claims serve to fortify the patent, providing fallback positions if broader claims are challenged or invalidated.
Claim Strength and Vulnerabilities
The robustness of RU2765076 hinges on the novelty, inventive step, and industrial applicability of the claimed subject matter. Initial examination indicates:
- The chemical structure distinguishes over prior art, citing recent patent literature and scientific publications.
- The synthesis process introduces novel steps not found in existing patents, supported by experimental data.
- Therapeutic claims align with emerging research but may face scrutiny if prior art suggests similar uses.
Potential vulnerabilities include arguments of obviousness if similar compounds or methods exist in prior disclosures, emphasizing the importance of detailed distinctions in claim language.
Patent Landscape Context
1. Global and Regional Patent Filings
A review of comparable patents indicates:
- Several filings in the European Patent Office (EPO) and United States Patent and Trademark Office (USPTO) relate to similar chemical entities, primarily targeting neurodegenerative disease treatment. These prior arts focus on structurally analogous compounds with overlapping therapeutic indications.
- Russian patent RU2691248, filed in 2017, describes a different class of neuroprotective compounds but shares structural motifs with RU2765076, suggesting potential for overlapping claims or later infringement claims.
2. Patent Family and Exclusivity
RU2765076 belongs to a broader patent family filed in Eurasia, including applications in countries like Kazakhstan and Belarus, extending enforceability across key Russian allied markets. The patent provides exclusivity until 2039, assuming maintenance fees are paid annually.
3. Competitive Landscape
The Russian pharmaceutical patent sphere exhibits active filings in the neuropharmaceutical and oncology domains. Notably:
- Several patents by domestic firms, such as OOO Pharmashelf and JSC Biotek, focus on similar chemical structures.
- International entities, including Pfizer and Novartis, maintain ecosystem-wide patent portfolios that could encroach upon or complement RU2765076.
4. Challenges and Litigation Risks
Given the densely populated patent landscape, patent challengers may invoke:
- Prior art obviation if similar compounds or synthesis methods are disclosed.
- Obviousness arguments if claims are deemed predictable or lacking inventive step against known references.
- Patent term and validity considerations, including compliance with Russian Patent Law, to ensure enforceability.
Legal and Strategic Implications
RU2765076’s scope provides a strong foundation for protecting innovative compounds and manufacturing processes, bolstering exclusivity rights within Russia. Strategic patenting around derivatives and manufacturing methods helps defend against generic competition. However, the risk of invalidation from prior art necessitates continuous monitoring and potential supplementary patent filings to extend protection.
Conclusion
Patent RU2765076 exemplifies a carefully crafted chemical and process patent aligned with Russian patent law, offering meaningful protection for a novel pharmaceutical compound and its production route. Its broad claims on chemical structures and manufacturing methods create a substantial barrier to entry for competitors, especially if complemented by a robust patent family portfolio. Business strategies should involve vigilant monitoring of the patent landscape, preparing for potential invalidation challenges, and exploring extension through additional filings or licensing.
Key Takeaways
- RU2765076's scope encompasses a specific pharmaceutical compound, its synthesis, and therapeutic uses, with well-defined structural and process claims.
- The patent's strength depends on the novelty and inventive step over prior art, with potential vulnerabilities in overlaps with existing chemical patents.
- The patent landscape in Russia and Eurasia is active, especially in neuropharmaceuticals, requiring ongoing patent monitoring.
- Strategic patent management, including derivative and formulation claims, can reinforce market exclusivity.
- Legal challenges, including prior art and obviousness assertions, are credible threats that necessitate comprehensive patent prosecution and defense.
FAQs
1. What is the main innovation claimed by RU2765076?
The patent claims a novel chemical compound with unique structural features, alongside a proprietary synthesis process and specific therapeutic applications, primarily targeting neurodegenerative diseases.
2. How does RU2765076 compare to international patents in the same field?
While similar compounds exist in international patents, RU2765076 specifically claims a unique structural embodiment and manufacturing process optimized for the Russian pharmaceutical market, providing regional exclusivity.
3. Can this patent prevent the manufacturing of similar compounds in Russia?
Yes, if the claims are upheld and valid, RU2765076 gives the patent holder exclusive rights to the claimed chemical structures and processes within Russia, effectively blocking generic manufacturing.
4. What are potential risks to the patent's validity?
Prior art disclosures, obviousness, or insufficient inventive step can challenge RU2765076’s validity, especially if similar compounds or methods are publicly available or well-known.
5. How should patent owners defend against challenges?
Strengthening the patent through additional claims, providing extensive experimental data, conducting freedom-to-operate searches, and pursuing supplementary patent filings are key strategies for defending the patent.
Sources
[1] Russian Patent Office (Rospatent) official database.
[2] European Patent Office (EPO) Patent Search.
[3] Scientific publications related to neuropharmaceutical compounds.
[4] Patent landscape reports on Russian pharmaceutical patents.
